311.32
Cencora Inc (COR) 最新ニュース
COR|Cencora Inc|Price:311.235|Chg%:+1.345 - TradingKey
Cencora Inc (COR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cencora Inc (COR) Cash Flow - TradingKey
Cencora, Inc. (COR) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora (COR) Q2 2026 Earnings Call Transcript - Fortune
Cencora, Inc. (COR) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
How Cencora’s Valuation Re‑Rating At Cencora (COR) Has Changed Its Investment Story - simplywall.st
Is Cencora (COR) Still Trading At A Discount As Its P E Rerating Gains Pace? - Yahoo Finance
Cencora, Inc. (COR) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora, Inc. (COR) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora, Inc. (COR) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora Inc (COR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cencora Inc (COR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cencora, Inc. (COR) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Cencora (COR) Stock Could Be 39% Below Fair Value - simplywall.st
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
A4EQAC Bond Risk Profile - TradingView
Here's Why You Should Add Cencora Stock to Your Portfolio Now - TradingView
Zacks.com featured highlights include AIM ImmunoTech, Hasbro, Fox, Cencora and Intuitive Surgical - Yahoo Finance
COR|Cencora Inc|Price:310.184|Chg%:+0.294 - TradingKey
Cencora stock holds steady as investors await fresh numbers - AD HOC NEWS
Cencora Inc (COR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cencora, Inc. (0HF3) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora, Inc. (0HF3) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Cencora stock trades steady as specialty distribution scale and recent earnings shape investor view - AD HOC NEWS
COR stock consolidates after strong fiscal 2025 results and guidance update - Ad-hoc-news.de
Cencora: Specialty Infrastructure Is Rewriting The Distributor Model (NYSE:COR) - Seeking Alpha
Cencora earnings preview: What to expect - MSN
ABC5953643 Bond Risk Profile - TradingView
Cencora stock trades steadily as pharmaceuticals distributor highlights rising revenue and earnings - Ad-hoc-news.de
Cencora, Inc. Stock 12‑Month Price Target Raised to $354.58, Implies 17% Upside - TradingView
ETFs Investing in Cencora, Inc. Stocks - TradingView
Cencora stock trades near record levels as earnings and guidance underpin healthcare distribution gr - Ad-hoc-news.de
Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch
Cencora stock holds firm as revenue and profit trends stay in focus - Ad-hoc-news.de
US3073EBC8 Bond Risk Profile - TradingView
Cencora stock trades near record levels as specialty distribution growth supports earnings - AD HOC NEWS
Steve Collis: Pharmaceutical Distribution Leader and Former Chairman, President, and CEO of Cencora - BBN Times
Cencora stock holds after fiscal 2026 growth update - ad-hoc-news.de
Cencora stock trades steadily as recent earnings highlight solid revenue growth - ad-hoc-news.de
XS3071246378 Bond Risk Profile - TradingView
XS3071246378 Bond Coupon Profile — Rate & Payments - TradingView
ABC6310083 Bond Coupon Profile — Rate & Payments - TradingView
XS3071246378 Bond Profile — Key Metrics - TradingView
Cencora stock trades steadily as specialty distribution growth supports earnings - Ad-hoc-news.de
Fund Update: 235,570 CENCORA (COR) shares added to FORT WASHINGTON INVESTMENT ADVISORS INC |OH| portfolio - Quiver Quantitative
Cencora Earnings Preview: What to Expect - inkl
A1ZW87 Bond Coupon Profile — Rate & Payments - TradingView
Lobbying Update: $60,000 of CENCORA INC. lobbying was just disclosed - Quiver Quantitative
ABC6310086 Bond Profile — Key Metrics - TradingView
Is Cencora Inc (COR) Overvalued After 3.9% Rally? GF Value Says - GuruFocus
Cencora stock reflects steady healthcare distribution role as investors track U.S. drug spending tre - ad-hoc-news.de
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
ABC5953320 Bond Risk Profile - TradingView
ABC4571978 Bond Coupon Profile — Rate & Payments - TradingView
How Cencora’s Revenue Miss Amid Growth Will Impact Cencora (COR) Investors - simplywall.st
ABC5953320 Bond Profile — Key Metrics - TradingView
ABC6310084 Bond Coupon Profile — Rate & Payments - TradingView
ABGB Bond Profile — Key Metrics - TradingView
ABC6310085 Bond Coupon Profile — Rate & Payments - TradingView
ABC4571978 Bond Profile — Key Metrics - TradingView
Cencora stock reflects steady growth as healthcare distribution evolves - Ad Hoc News
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cencora (COR) Following Soft Earnings Is The Stock Starting To Look Undervalued - simplywall.st
大文字化:
|
ボリューム (24 時間):